RecruitingNCT06918756

Development of a Cough Control Questionnaire (CCQ)

The Development and Validation of a Cough Control Questionnaire


Sponsor

King's College Hospital NHS Trust

Enrollment

100 participants

Start Date

Apr 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic cough (\>8 weeks in duration) affects 5-12% of the global population, and is associated with considerable health status impairment and comorbidities. Currently, there are validated severity and impact outcome measures whilst objective measures with cough frequency monitoring is not available in routine clinical practice. Unlike other chronic respiratory diseases, namely asthma, there are no validated dedicated tools to assess the control of cough as a disease. This study aims to develop a validated patient-focused tool to assess the control of cough, which may be useful to evaluate the benefit and value of treatments in both clinical and research settings.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Focus group interviews, Objective cough measures, and others for people with cough. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaires

Completion of new questionnaire in addition to other patient reported outcome measures that measure cough severity and cough-related quality of life.

OTHERFocus group interviews

Semi-structured focus group interviews for patients with refractory chronic cough

OTHERObjective cough measures

Cough monitoring and cough sensitivity testing.


Locations(1)

King's College Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06918756


Related Trials